Skip to main content
Osama Elzaafarany, MD, Oncology, Tampa, FL

Osama Elzaafarany MD

Neuro-Oncology


Neuro-Oncology Fellow, Moffitt Cancer Center, Tampa, FL | Doctorate in Oncology, Alexandria University, Egypt | YouTube Channel Founder: Cancer Education (3.3M+ Views, 44K+ Subscribers)

Join to View Full Profile
  • 12902 Usf Magnolia DrTampa, FL 33612

  • Phone+1 813-745-0351

  • Fax+1 813-449-8246

Dr. Elzaafarany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • As a dedicated neuro-oncology fellow at Moffitt Cancer Center, I am passionate about advancing cancer care through clinical expertise, innovative research, and patient advocacy. My journey began in Egypt, where I completed my residency in clinical oncology at Alexandria University Hospitals (2008–2011), laying the foundation for my career in oncology. I later earned a Doctorate in Clinical Oncology from Alexandria University in 2019, further solidifying my commitment to tackling complex challenges in cancer treatment.

    My research focuses on glioblastoma multiforme (GBM), the integration of artificial intelligence (AI) in oncology, and reducing treatment-related toxicities. During my time in Dr. Purow’s laboratory at the University of Virginia, I conducted bench research testing in vitro single-agent and combination therapies in glioblastoma and melanoma. I gained expertise in complex co-culture assays and cell culture techniques, with readouts including viability and luciferase assays. Notably, I identified an unexpected single-agent toxicity of high-concentration niacin against melanoma cells, a finding that holds potential for future therapeutic exploration.

    Beyond my clinical and research endeavors, I am a strong advocate for patient education. I founded a YouTube channel aimed at educating Arabic-speaking cancer patients, which has grown into a vital resource with over 3.3 million views and 44.400 subscribers. This platform empowers patients and families with accessible, culturally relevant information, reflecting my belief in the transformative power of knowledge in healthcare.

    Through collaboration, innovation, and advocacy, I aim to contribute meaningfully to the global oncology community while striving to improve the lives of patients worldwide.
  • Dr. Osama Elzaafarany's YouTube Channel

    Founder of a YouTube channel with 44K+ subscribers and 3.3M+ views aimed at educating Arabic-speaking cancer patients about their disease and its treatment.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterFellowship, Neuro-Oncology, 2022 - 2023
  • Alexandrina University
    Alexandrina UniversityDoctorate, Oncology, 2012 - 2019
  • Alexandrina Universty Hospitals
    Alexandrina Universty HospitalsResidency, 2008 - 2011
  • Alexanderia medical school
    Alexanderia medical school Class of 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - 2026
  • VA State Medical License
    VA State Medical License 2025 - 2026
  • ECFMG Certified
    Educational Commission for Foreign Medical GraduatesECFMG Certified

Awards, Honors, & Recognition

  • Selected Mentee – ASCO Virtual Mentorship Program, mentored by Dr. Solmaz Sahebjam, Johns Hopkins University. American Society of Clinical Oncology (ASCO), 2025-2026
  • AMAAC International Fellowship Arab Medical Association Against Cancer, 2013
  • SNO International Scholarship Society for Neuro-Oncology, 2013

Publications & Presentations

PubMed

Journal Articles

  • The magnitude of benefit from adding taxanes to anthracyclines in the adjuvant settings of breast cancer: discussion of large trials and meta-analyses.  
    Osama H. Elzaafarany, Atlal Abusanad, J Cancer Metastasis Treat, 3/14/2018

Abstracts/Posters

  • Clinical and Molecular Characterization of Clinically Diagnosed Schwannomas: A Cohort Study from Moffitt Cancer Center
    Elzaafarany OH, Troutman S, Cory R, Brzosowicz J, Walko C, Tran N, Kissil J, Mokhtari S, Children’s Tumor Foundation 2025 NF Conference, Washington, DC, USA, 6/21/2025
  • Decoding NF2: Clinical and Genetic Insights from a Rare Disease Cohort
    Elzaafarany OH, Tran N, Kissil J, Troutman S, Cory R, Brzosowicz J, Mokhtari S, Moffitt Scientific Symposium 2025, Tampa, FL, 5/2025
  • CLIPPERS Case Report: More Than Meets the Pontine Nuclei
    Rincones Alfonso A, Elzaafarany OH, Mokhtari S, Iacono D, Jaffer M, Peguero E, American Academy of Neurology 2025 Annual Meeting, San Diego, CA., 4/18/2025

Other

  • PREPRINT: Optic pathway glioma: current treatment approaches and ongoing clinical trials—a review article 
    Osama Elzaafarany, MD; Sarah Elhomosany, MD; Alexandra Rincones, MD; Vincent Dlugi; Sepideh Mokhtari, MD
    https://doi.org/10.21203/rs.3.rs-6882947/v1
    Research Square - 6/16/2025

Research History

  • Research Associate, Purow Lab, Department of Neurology, University of VirginiaI worked for a year in Purow’s laboratory doing bench research, testing in vitro single-agent and combination therapies in glioblastoma and melanoma. I learned to do complex co-culture assays as well as more straightforward cell culture, with readouts including viability assays and luciferase assays2023 - 2024

Professional Memberships

Other Languages

  • Arabic

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: